Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PHIBRO ANIMAL HEALTH CORPPAHC · Entity 4671 | Sr VP, Human Resources | March 14, 2017 | March 17, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PHIBRO ANIMAL HEALTH CORP
Report date March 14, 2017 · Filed March 17, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2017-03-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-03-14 · Exercise / conversion · Acquired 5,000 · Balance 5,000 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. Row 2 · 2017-03-14 · Sale · Disposed 5,000 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.90 to $27.38, inclusive. |
| Option to purchase Class A Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.83 · Expires 2019-02-28 | Direct | 4,150 |
Reported balance
After 2017-03-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-03-14 · Exercise / conversion · Disposed 5,000 · Balance 4,150 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.90 to $27.38, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2017 Filed Mar 17, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 5,000 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-002513 · t1700787.xml · derivative · entry 3 Welch Daniel A · CIK 0001603461 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,150 Underlying: Class A Common Stock · 5,000 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. Read SEC document |
| March 14, 2017 Filed Mar 17, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 5,000 | $27.22 | $136,100.00 |
DisclosureSEC source: 0001571049-17-002513 · t1700787.xml · nonDerivative · entry 2 Welch Daniel A · CIK 0001603461 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.90 to $27.38, inclusive. Read SEC document |
| March 14, 2017 Filed Mar 17, 2017 01:01 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 5,000 | $11.83 | $59,150.00 |
DisclosureSEC source: 0001571049-17-002513 · t1700787.xml · nonDerivative · entry 1 Welch Daniel A · CIK 0001603461 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. Read SEC document |
| February 27, 2017 Filed Mar 16, 2017 23:51 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 1,900 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-002511 · t1700607_x2.xml · derivative · entry 5 Welch Daniel A · CIK 0001603461 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,150 Underlying: Class A Common Stock · 1,900 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · date: Report is being submitted late due to a technical error. F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. Read SEC document |
| February 27, 2017 Filed Mar 16, 2017 23:51 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 3,100 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-002511 · t1700607_x2.xml · derivative · entry 4 Welch Daniel A · CIK 0001603461 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,100 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: The Date Exercisable for the securities included on this line was incorrectly reported in the Form 4 for Mr. Welch filed on February 16, 2017. The information in this line reflects the correct Date Exercisable for the Options to purchase Class A Common Stock. F6 · date: Report is being submitted late due to a technical error. F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. Read SEC document |
| February 27, 2017 Filed Mar 16, 2017 23:51 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 5,000 | $28.30 | $141,500.00 |
DisclosureSEC source: 0001571049-17-002511 · t1700607_x2.xml · nonDerivative · entry 3 Welch Daniel A · CIK 0001603461 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F6 · date: Report is being submitted late due to a technical error. F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.95 to $28.75, inclusive. Read SEC document |
| February 27, 2017 Filed Mar 16, 2017 23:51 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 1,900 | $11.83 | $22,477.00 |
DisclosureSEC source: 0001571049-17-002511 · t1700607_x2.xml · nonDerivative · entry 2 Welch Daniel A · CIK 0001603461 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Reflects conversions of options with an exercisable date of March 1, 2013. F6 · date: Report is being submitted late due to a technical error. F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. Read SEC document |
| February 27, 2017 Filed Mar 16, 2017 23:51 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 3,100 | $11.83 | $36,673.00 |
DisclosureSEC source: 0001571049-17-002511 · t1700607_x2.xml · nonDerivative · entry 1 Welch Daniel A · CIK 0001603461 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects conversions of options with an exercisable date of March 1, 2012. F6 · date: Report is being submitted late due to a technical error. F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 5,000 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-001434 · t1700530_x3.xml · derivative · entry 3 Welch Daniel A · CIK 0001603461 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100 Underlying: Class A Common Stock · 5,000 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 5,000 | $29.55 | $147,750.00 |
DisclosureSEC source: 0001571049-17-001434 · t1700530_x3.xml · nonDerivative · entry 2 Welch Daniel A · CIK 0001603461 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.15 to $29.95, inclusive. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 02:30 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 5,000 | $11.83 | $59,150.00 |
DisclosureSEC source: 0001571049-17-001434 · t1700530_x3.xml · nonDerivative · entry 1 Welch Daniel A · CIK 0001603461 · Sr VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.